If you are taking Spinraza® (nusinersen) for spinal muscular atrophy (SMA), then you may be curious about Evrysdi® (risdiplam). Both therapies are available in the United States, but there are a few things to consider when comparing them. Spinraza was approved in 2016 to treat SMA in children and adults. It is delivered through spinal injections. Evrysdi was approved in 2020 to treat SMA in adults and children 2 months and older. It is a liquid drug that can be swallowed or given in a feeding tube. Both drugs are approved for all types of SMA . . .
Published on SpinalMuscularAtrophy.net on May 5, 2022